title: Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee, Memphis 38163.
authors.forename: S J
authors.initials: SJ
authors.lastname: Phelps
authors.forename: L A
authors.initials: LA
authors.lastname: Baldree
authors.forename: B A
authors.initials: BA
authors.lastname: Boucher
authors.forename: S L
authors.initials: SL
authors.lastname: Hogue
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D017109:Akathisia, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D000755:Anemia, Sickle Cell / Q000150:complications; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis; D003937:Diagnosis, Differential; D016903:Drug Monitoring / Q000379:methods / Q000592:standards*; D005260:Female; D016231:Fluorescence Polarization Immunoassay; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy; D006212:Hallucinations / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007262:Infusions, Intravenous; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D011485:Protein Binding; D006435:Renal Dialysis; D012640:Seizures / Q000150:complications / Q000188:drug therapy*; D014462:Ultrafiltration
chemical_list: D010672:Phenytoin